Cover of Steven D. Schwartz (EDT), Aaron Nagiel (EDT), Robert Lanza (EDT): Cellular Therapies for Retinal Disease

Steven D. Schwartz (EDT), Aaron Nagiel (EDT), Robert Lanza (EDT) Cellular Therapies for Retinal Disease

A Strategic Approach

Price for Eshop: 3365 Kč (€ 134.6)

VAT 0% included

New

E-book delivered electronically online

E-Book information

Springer International Publishing

2017

EPub, PDF
How do I buy e-book?

978-3-319-49479-1

3-319-49479-1

Annotation

This book familiarizes the reader with the current landscape of cell-based therapies for the treatment of retinal disease, including diseases that affect the choriocapillaris, retinal pigment epithelium, photoreceptors, and retinal ganglion cells. Instead of utilizing a disease-centric approach to the topic, this book-edited by two world-renowned stem cell scientists-focuses on strategies for developing and transplanting the cells. This includes the creation of replacement cells, cell-based neuroprotection, and in vitro disease modeling and testing. The final chapters briefly review parallel approaches that do not directly utilize cellular transplantation.The use of cellular transplantation to treat retinal disease has recently become a viable and exciting therapeutic approach. The visibility of the retina and its laminar cellular architecture render it an ideal organ for the development of surgically delivered cellular therapies. Having an in-depth understanding of the current state of cell therapy for the eye is an essential first step toward utilizing similar approaches in other organs. Ophthalmologists, translational clinician-scientists, stem cell scientists, and researchers interested in eye disease will find Cellular Therapies for Retinal Disease: A Strategic Approach essential reading and it is also suitable for workshops or courses at the undergraduate or Ph.D. level.

Ask question

You can ask us about this book and we'll send an answer to your e-mail.